Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasm Metastasis × lobaplatin × Clear all

Phase

Status

Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 3 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Peritoneal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Liver, Cancer of, Primary Resectable 1 Hepatocellular Carcinoma Resectable 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Advanced Gastric Cancer 1

Interventions

Fluorouracil 18 Oxaliplatin 15 Capecitabine 15 Leucovorin 13 Irinotecan 11 Gemcitabine 11 Drug Therapy 11 Cetuximab 10 Radiosurgery 9 Cisplatin 9 Bevacizumab 9 Docetaxel 8 Radiotherapy 6 Paclitaxel 6 Neoadjuvant Therapy 6 Everolimus 6 spartalizumab 5 pembrolizumab 5 Trastuzumab 5 Sunitinib 5 S 1 (combination) 5 Cyclophosphamide 5 Chemotherapy, Adjuvant 5 Carboplatin 5 manganese chloride 4 Surgical Procedures, Operative 4 Sorafenib 4 Nivolumab 4 Immunotherapy 4 Immune Checkpoint Inhibitors 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04808466 2022-02-21

WUHIPEC01

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Unknown

Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡